X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2021) 2021
Publication (334) 334
Book Review (66) 66
Newsletter (29) 29
Book Chapter (22) 22
Book / eBook (10) 10
Conference Proceeding (6) 6
Newspaper Article (3) 3
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1313) 1313
index medicus (1312) 1312
animals (1063) 1063
immunology (921) 921
b cells (782) 782
mice (568) 568
b-lymphocytes - immunology (408) 408
b-cells (391) 391
t cells (384) 384
dendritic cells (360) 360
female (335) 335
lymphocytes (331) 331
autoimmunity (285) 285
cytokines (282) 282
cell biology (257) 257
immune system (255) 255
male (255) 255
research (255) 255
inflammation (240) 240
analysis (239) 239
antigens (239) 239
signal transduction (239) 239
proteins (227) 227
t-cells (227) 227
expression (222) 222
health aspects (221) 221
article (218) 218
oncology (211) 211
activation (210) 210
systemic-lupus-erythematosus (210) 210
immune response (205) 205
lymphocytes b (201) 201
apoptosis (200) 200
research article (196) 196
cancer (195) 195
hematology (192) 192
review (192) 192
systemic lupus erythematosus (191) 191
t-lymphocytes - immunology (185) 185
gene expression (182) 182
b-lymphocytes - metabolism (179) 179
immunotherapy (177) 177
mice, inbred c57bl (172) 172
rheumatology (172) 172
autoimmune diseases (167) 167
medicine (166) 166
biochemistry & molecular biology (162) 162
lymphocytes t (158) 158
physiological aspects (154) 154
b-cell (153) 153
cell differentiation (151) 151
multidisciplinary sciences (151) 151
lupus (150) 150
in-vivo (149) 149
antibodies (148) 148
regulatory t-cells (147) 147
rodents (147) 147
cells, cultured (146) 146
rheumatoid-arthritis (145) 145
flow cytometry (143) 143
pharmacology & pharmacy (138) 138
care and treatment (136) 136
b-lymphocytes - drug effects (133) 133
medicine, research & experimental (133) 133
disease models, animal (132) 132
nf-kappa-b (130) 130
adult (129) 129
science (128) 128
baff (126) 126
development and progression (126) 126
necrosis-factor family (125) 125
pathogenesis (124) 124
lupus erythematosus, systemic - immunology (123) 123
toll-like receptors (123) 123
genetic aspects (122) 122
middle aged (122) 122
immunoglobulins (121) 121
mice, knockout (121) 121
biology (119) 119
disease (118) 118
immunity (118) 118
lymphomas (117) 117
autoimmune-disease (116) 116
ligands (115) 115
medical research (115) 115
rheumatoid arthritis (114) 114
differentiation (113) 113
cell proliferation (110) 110
t cell receptors (109) 109
dendritic cells - immunology (108) 108
receptor (106) 106
autoantibodies (105) 105
b-lymphocytes - cytology (105) 105
kinases (103) 103
allergy (102) 102
cutting edge (101) 101
chronic lymphocytic-leukemia (99) 99
allergy and immunology (98) 98
arthritis (97) 97
b-lymphocyte stimulator (97) 97
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Gene Therapy, ISSN 1043-0342, 05/2018, Volume 29, Issue 5, pp. 585 - 601
B-cell maturation antigen (BCMA) expression has been proposed as a marker for the identification of malignant plasma cells in patients with multiple myeloma... 
Research Articles | gene therapy | multiple myeloma | BCMA | CAR | adoptive cell therapy | immunotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | ANTITUMOR-ACTIVITY | GENETIC-MODIFICATION | CANCER | THERAPY | ENHANCED SURVIVAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | LENTIVIRAL VECTOR | MYELOMA CELLS | GENETICS & HEREDITY | BETA-THALASSEMIA | APRIL | Hematologic Neoplasms - therapy | Humans | Hematologic Neoplasms - pathology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Multiple Myeloma - therapy | CD3 Complex - genetics | T-Lymphocytes - drug effects | Lentivirus - genetics | Gene Expression Regulation, Neoplastic - drug effects | Cytotoxicity, Immunologic - drug effects | B-Cell Maturation Antigen - antagonists & inhibitors | B-Cell Maturation Antigen - immunology | Immunotherapy, Adoptive | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Xenograft Model Antitumor Assays | Receptors, Chimeric Antigen - therapeutic use | Multiple Myeloma - pathology | Animals | Receptors, Chimeric Antigen - immunology | CD3 Complex - immunology | Cell Line, Tumor | T-Lymphocytes - immunology | Hematologic Neoplasms - genetics | Mice | Hematologic Neoplasms - immunology | Multiple Myeloma - genetics | Biotechnology | Animal models | Intravenous administration | Leukemia | Multiple myeloma | Lymphocytes T | Receptors | Lymphocytes | Peripheral blood | Antigens | Chronic lymphatic leukemia | CD137 antigen | Hematology | Maturation | Tumor cells | Therapeutic applications | Pharmacology | Tumor cell lines | Lymphatic leukemia | Lymphoma | Molecular chains | Burkitt's lymphoma | Lymphocytes B | Mantle cell lymphoma | Cell lines | Plasma cells | Lymphomas | Tumors
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2016, Volume 174, Issue 6, pp. 911 - 922
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2019, Volume 380, Issue 18, pp. 1726 - 1737
Journal Article
Journal Article
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 05/2017, Volume 19, Issue 1, pp. 91 - 18
Journal Article
Seminars in Immunology, ISSN 1044-5323, 2006, Volume 18, Issue 5, pp. 263 - 275
BAFF, APRIL and their receptors play important immunological roles, especially in the B cell arm of the immune system. A number of splice isoforms have been... 
Signaling | BAFF | B cells | Structure | Splice variants | MATURATION ANTIGEN | signaling | PROTEIN-KINASE | splice variants | COMMON VARIABLE IMMUNODEFICIENCY | LYMPHOCYTE STIMULATOR | T-CELL | IMMUNOLOGY | structure | TNF FAMILY | CELL-ACTIVATING FACTOR | NECROSIS-FACTOR FAMILY | NF-KAPPA-B | AUTOIMMUNE-DISEASE | B-Cell Activating Factor - physiology | Alternative Splicing | Humans | Substrate Specificity | Structure-Activity Relationship | Lymphocyte Subsets - immunology | Immunoglobulin Class Switching - physiology | Protein Kinase C-delta - antagonists & inhibitors | B-Cell Activating Factor - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - chemistry | B-Cell Activation Factor Receptor - genetics | B-Cell Activation Factor Receptor - immunology | B-Cell Activation Factor Receptor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | B-Lymphocytes - cytology | Transmembrane Activator and CAML Interactor Protein - chemistry | Signal Transduction | B-Cell Maturation Antigen - physiology | Lymphocyte Activation | B-Cell Activating Factor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - physiology | Models, Molecular | B-Cell Activation Factor Receptor - physiology | Transmembrane Activator and CAML Interactor Protein - physiology | Protein Interaction Mapping | Transmembrane Activator and CAML Interactor Protein - genetics | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | NF-kappa B - physiology | Protein Conformation | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | NF-kappa B p50 Subunit - physiology | Apoptosis - physiology | Transmembrane Activator and CAML Interactor Protein - immunology | Antigen Presentation - physiology
Journal Article
PLoS Pathogens, ISSN 1553-7366, 12/2011, Volume 7, Issue 12, p. e1002407
Journal Article
Blood, ISSN 0006-4971, 04/2004, Volume 103, Issue 8, pp. 3148 - 3157
Identification of growth factors in neoplasias may be a target for future therapies by blocking either growth factor receptor interaction or the induced... 
B-LYMPHOCYTE STIMULATOR | TNF RECEPTOR | SYSTEMIC-LUPUS-ERYTHEMATOSUS | NECROSIS-FACTOR FAMILY | MATURATION PROTEIN | MONOCLONAL-ANTIBODY | GROWTH-FACTOR | MALIGNANT PLASMA-CELLS | HEMATOLOGY | NF-KAPPA-B | HUMAN MULTIPLE-MYELOMA | Interleukin-6 - antagonists & inhibitors | Apoptosis - drug effects | Humans | Tumor Necrosis Factor-alpha - genetics | Neuropeptides - physiology | RNA, Messenger - metabolism | RNA, Neoplasm - metabolism | Receptors, Tumor Necrosis Factor - physiology | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Membrane Proteins - physiology | Base Sequence | Plasma Cells - metabolism | Membrane Proteins - metabolism | Neuropeptides - genetics | Nuclear Proteins - genetics | Interleukin-6 - metabolism | Multiple Myeloma - physiopathology | Receptors, Tumor Necrosis Factor - genetics | Receptors, Tumor Necrosis Factor - metabolism | Gene Expression | Signal Transduction | Membrane Proteins - genetics | RNA, Messenger - genetics | Transmembrane Activator and CAML Interactor Protein | B-Cell Activation Factor Receptor | B-Cell Maturation Antigen | Multiple Myeloma - pathology | B-Cell Activating Factor | Tumor Necrosis Factor-alpha - physiology | Cell Line, Tumor | RNA, Neoplasm - genetics | Nuclear Proteins - physiology | Apoptosis - physiology | Multiple Myeloma - genetics | Dexamethasone | Hematology | Biochemistry, Molecular Biology | Neuropeptides | Nuclear Proteins | Interleukin-6 | Membrane Proteins | Life Sciences | Human health and pathology | Apoptosis | Multiple Myeloma | Cancer | pathology | RNA | Receptors | genetics | pharmacology | Tumor | Plasma Cells | Cell Line | drug therapy | physiology | drug effects | Messenger | Tumor Necrosis Factor-alpha | antagonists & inhibitors | Neoplasm | physiopathology | metabolism | Tumor Necrosis Factor
Journal Article
INTERNATIONAL IMMUNOLOGY, ISSN 0953-8178, 10/2006, Volume 18, Issue 10, pp. 1473 - 1485
BAFF [B cell-activating factor of the tumour necrosis factor (TNF) family] and APRIL (a proliferation-inducing ligand) are two TNF family members with shared... 
B-LYMPHOCYTE STIMULATOR | TNF RECEPTOR | MYELIN/OLIGODENDROCYTE GLYCOPROTEIN | MYELIN OLIGODENDROCYTE GLYCOPROTEIN | APRIL-DEFICIENT MICE | MATURATION ANTIGEN | MULTIPLE-SCLEROSIS | NECROSIS-FACTOR FAMILY | CD4(+) T-CELLS | ANTIGEN-PRESENTING CELLS | IMMUNOLOGY | Encephalomyelitis, Autoimmune, Experimental - immunology | Immunoglobulin Fc Fragments - administration & dosage | Multiple Sclerosis - chemically induced | Myelin-Associated Glycoprotein - toxicity | Immunity, Cellular - drug effects | Encephalomyelitis, Autoimmune, Experimental - chemically induced | B-Cell Activating Factor - antagonists & inhibitors | B-Cell Activating Factor - immunology | Female | Recombinant Fusion Proteins - administration & dosage | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Antibody Formation - immunology | Myelin-Associated Glycoprotein - administration & dosage | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Myelin-Oligodendrocyte Glycoprotein | Tumor Necrosis Factor Ligand Superfamily Member 13 - antagonists & inhibitors | Immunity, Cellular - immunology | Animals | B-Cell Maturation Antigen - administration & dosage | B-Lymphocytes - immunology | Antibody Formation - drug effects | Multiple Sclerosis - immunology | Myelin Proteins | Mice, Inbred NOD | T-Lymphocytes - immunology | Mice | Multiple Sclerosis - drug therapy
Journal Article